Table 1.
Summary of the included systematic reviews
| Author (year) | Search period | Databases searched | Number of studies | Number of patients | Tool used for quality assessment | Method of analysis | Findings |
|---|---|---|---|---|---|---|---|
| Shirvani (2017) | Up to March 2015 | Cochrane Databases for Systematic Review, Pub Med, Science Direct, Scopus, and Google Scholar | 16 | 1900 | Cochrane collaboration risk of bias tool | MA | Indomethacin, meloxicam, piroxicam, diclofenac potassium, acetaminophen+opioid |
| Nagendrababu (2018) | Up to September 2017 | PubMed, EBSCOhost, and Scopus | 13 | 1174 | Cochrane collaboration risk of bias tool | MA | Ibuprofen (>400 mg) |
| De Gues (2019) | Up to August 2017 | PubMed, Scopus, Web of Science, LILACS, BBO, Cochrane Library, SIGLE, and grey literature | 7 | NR | Cochrane collaboration risk of bias tool | MA | Ibuprofen |
| Karapinar-Kazandag (2019) | Up to April 2018 | Cochrane Library database and PubMed | 35 | NR | Cochrane collaboration risk of bias tool | SR | Ibuprofen, ketamine (oral administration) |
MA: Meta-analysis, SR: Systematic review, NR: Not reported